RETRACTED: Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study

Hossein-Ardeschir Ghofrani, Gérald Simonneau, Andrea M D'Armini, Peter Fedullo, Luke S Howard, Xavier Jaïs, David P Jenkins, Zhi-Cheng Jing, Michael M Madani, Nicolas Martin, Eckhard Mayer, Kelly Papadakis, Dominik Richard, Nick H Kim, Irene Lang, Christian Kähler, Marion Delcroix, Zoheir Bshouty, Pablo Sepulveda Varela, Zhi-Cheng Jing, Yuanhua Yang, Jinming Liu, Gangcheng Zhang, Nuofu Zhang, Yuhong Mi, Xianyang Zhu, Pavel Jansa, Xavier Jaïs, Grégoire Prévot, Hélène Bouvaist, Olivier Sanchez, Friedrich Grimminger, Matthias Held, Heinrike Wilkens, Stephan Rosenkranz, Ekkehard Grünig, Kristóf Karlócai, András Temesvári, Istvan Edes, Sigita Aidietienė, Skaidrius Miliauskas, Tomas Rene Pulido Zamudio, Carlos Jerjes Sanchez, Anton Vonk Noordegraaf, Jerzy Lewczuk, Piotr Podolec, Jarosław Kasprzak, Tatiana Mularek-Kubzdela, Ryszard Grzywna, Keertan Dheda, Olga Moiseeva, Alexander Chernyavskiy, Vladimir Shipulin, Olga Barbarash, Tamila Martynyuk, Hyung-Kwan Kim, Jun-Bean Park, Jae Seung Lee, Rudolf Speich, Silvia Ulrich, John-David Aubert, Arintaya Phrommintikul, Nattapong Jaimchariyatam, Suree Sompradeekul, Zeynep Pinar Onen, Gulfer Okumus, Lyubomyr Solovey, Volodymyr Gavrysyuk, Luke Howard, Joanna Pepke-Zaba, Robin Condliffe, John McConnell, Kim Kerr, Lan Hieu Nguyen, Nguyen Vinh Pham

Open source

DOI
10.1016/s2213-2600(17)30305-3
Published
2017-10
Container
The Lancet Respiratory Medicine
Publisher
Elsevier BV
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s2213-2600-17-30305-3,
  title = {RETRACTED: Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study},
  author = {Hossein-Ardeschir Ghofrani and Gérald Simonneau and Andrea M D'Armini and Peter Fedullo and Luke S Howard and Xavier Jaïs and David P Jenkins and Zhi-Cheng Jing and Michael M Madani and Nicolas Martin and Eckhard Mayer and Kelly Papadakis and Dominik Richard and Nick H Kim and Irene Lang and Christian Kähler and Marion Delcroix and Zoheir Bshouty and Pablo Sepulveda Varela and Zhi-Cheng Jing and Yuanhua Yang and Jinming Liu and Gangcheng Zhang and Nuofu Zhang and Yuhong Mi and Xianyang Zhu and Pavel Jansa and Xavier Jaïs and Grégoire Prévot and Hélène Bouvaist and Olivier Sanchez and Friedrich Grimminger and Matthias Held and Heinrike Wilkens and Stephan Rosenkranz and Ekkehard Grünig and Kristóf Karlócai and András Temesvári and Istvan Edes and Sigita Aidietienė and Skaidrius Miliauskas and Tomas Rene Pulido Zamudio and Carlos Jerjes Sanchez and Anton Vonk Noordegraaf and Jerzy Lewczuk and Piotr Podolec and Jarosław Kasprzak and Tatiana Mularek-Kubzdela and Ryszard Grzywna and Keertan Dheda and Olga Moiseeva and Alexander Chernyavskiy and Vladimir Shipulin and Olga Barbarash and Tamila Martynyuk and Hyung-Kwan Kim and Jun-Bean Park and Jae Seung Lee and Rudolf Speich and Silvia Ulrich and John-David Aubert and Arintaya Phrommintikul and Nattapong Jaimchariyatam and Suree Sompradeekul and Zeynep Pinar Onen and Gulfer Okumus and Lyubomyr Solovey and Volodymyr Gavrysyuk and Luke Howard and Joanna Pepke-Zaba and Robin Condliffe and John McConnell and Kim Kerr and Lan Hieu Nguyen and Nguyen Vinh Pham},
  year = {2017},
  journal = {The Lancet Respiratory Medicine},
  doi = {10.1016/s2213-2600(17)30305-3},
  url = {https://doi.org/10.1016/s2213-2600(17)30305-3}
}

RIS

TY  - JOUR
TI  - RETRACTED: Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study
AU  - Hossein-Ardeschir Ghofrani
AU  - Gérald Simonneau
AU  - Andrea M D'Armini
AU  - Peter Fedullo
AU  - Luke S Howard
AU  - Xavier Jaïs
AU  - David P Jenkins
AU  - Zhi-Cheng Jing
AU  - Michael M Madani
AU  - Nicolas Martin
AU  - Eckhard Mayer
AU  - Kelly Papadakis
AU  - Dominik Richard
AU  - Nick H Kim
AU  - Irene Lang
AU  - Christian Kähler
AU  - Marion Delcroix
AU  - Zoheir Bshouty
AU  - Pablo Sepulveda Varela
AU  - Zhi-Cheng Jing
AU  - Yuanhua Yang
AU  - Jinming Liu
AU  - Gangcheng Zhang
AU  - Nuofu Zhang
AU  - Yuhong Mi
AU  - Xianyang Zhu
AU  - Pavel Jansa
AU  - Xavier Jaïs
AU  - Grégoire Prévot
AU  - Hélène Bouvaist
AU  - Olivier Sanchez
AU  - Friedrich Grimminger
AU  - Matthias Held
AU  - Heinrike Wilkens
AU  - Stephan Rosenkranz
AU  - Ekkehard Grünig
AU  - Kristóf Karlócai
AU  - András Temesvári
AU  - Istvan Edes
AU  - Sigita Aidietienė
AU  - Skaidrius Miliauskas
AU  - Tomas Rene Pulido Zamudio
AU  - Carlos Jerjes Sanchez
AU  - Anton Vonk Noordegraaf
AU  - Jerzy Lewczuk
AU  - Piotr Podolec
AU  - Jarosław Kasprzak
AU  - Tatiana Mularek-Kubzdela
AU  - Ryszard Grzywna
AU  - Keertan Dheda
AU  - Olga Moiseeva
AU  - Alexander Chernyavskiy
AU  - Vladimir Shipulin
AU  - Olga Barbarash
AU  - Tamila Martynyuk
AU  - Hyung-Kwan Kim
AU  - Jun-Bean Park
AU  - Jae Seung Lee
AU  - Rudolf Speich
AU  - Silvia Ulrich
AU  - John-David Aubert
AU  - Arintaya Phrommintikul
AU  - Nattapong Jaimchariyatam
AU  - Suree Sompradeekul
AU  - Zeynep Pinar Onen
AU  - Gulfer Okumus
AU  - Lyubomyr Solovey
AU  - Volodymyr Gavrysyuk
AU  - Luke Howard
AU  - Joanna Pepke-Zaba
AU  - Robin Condliffe
AU  - John McConnell
AU  - Kim Kerr
AU  - Lan Hieu Nguyen
AU  - Nguyen Vinh Pham
PY  - 2017
JO  - The Lancet Respiratory Medicine
DO  - 10.1016/s2213-2600(17)30305-3
UR  - https://doi.org/10.1016/s2213-2600(17)30305-3
ER  - 

APA

Ghofrani, H., Simonneau, G., D'Armini, A. M., Fedullo, P., Howard, L. S., Jaïs, X., Jenkins, D. P., Jing, Z., Madani, M. M., Martin, N., Mayer, E., Papadakis, K., Richard, D., Kim, N. H., Lang, I., Kähler, C., Delcroix, M., Bshouty, Z., Varela, P. S., Jing, Z., Yang, Y., Liu, J., Zhang, G., Zhang, N., Mi, Y., Zhu, X., Jansa, P., Jaïs, X., Prévot, G., Bouvaist, H., Sanchez, O., Grimminger, F., Held, M., Wilkens, H., Rosenkranz, S., Grünig, E., Karlócai, K., Temesvári, A., Edes, I., Aidietienė, S., Miliauskas, S., Zamudio, T. R. P., Sanchez, C. J., Noordegraaf, A. V., Lewczuk, J., Podolec, P., Kasprzak, J., Mularek-Kubzdela, T., Grzywna, R., Dheda, K., Moiseeva, O., Chernyavskiy, A., Shipulin, V., Barbarash, O., Martynyuk, T., Kim, H., Park, J., Lee, J. S., Speich, R., Ulrich, S., Aubert, J., Phrommintikul, A., Jaimchariyatam, N., Sompradeekul, S., Onen, Z. P., Okumus, G., Solovey, L., Gavrysyuk, V., Howard, L., Pepke-Zaba, J., Condliffe, R., McConnell, J., Kerr, K., Nguyen, L. H., & Pham, N. V. (2017). RETRACTED: Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study. The Lancet Respiratory Medicine. https://doi.org/10.1016/s2213-2600(17)30305-3

Source records